Aclaris Therapeutics Inc

General ticker "ACRS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $253.6M

Aclaris Therapeutics Inc follows the US Stock Market performance with the rate: 37.2%.

Estimated limits based on current volatility of 5.7%: low 2.74$, high 3.07$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.12$, 3.48$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.31$, 3.39$]

Financial Metrics affecting the ACRS estimates:

  • Negative: Non-GAAP EPS, $ of -1.55 <= 0.10
  • Negative: Operating profit margin, % of -75.70 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -53.38 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term ACRS quotes

Long-term ACRS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $6.76MM $29.75MM $31.25MM
Operating Expenses $96.48MM $119.61MM $128.61MM
Operating Income $-89.72MM $-89.85MM $-97.36MM
Non-Operating Income $-1.14MM $2.95MM $8.51MM
Interest Expense $0.00MM $4.70MM $0.00MM
R&D Expense $43.81MM $77.81MM $98.38MM
Income(Loss) $-90.86MM $-86.91MM $-88.85MM
Taxes $0.00MM $0.00MM $-0.37MM
Profit(Loss) $-90.86MM $-86.91MM $-88.48MM
Stockholders Equity $197.34MM $197.62MM $157.18MM
Inventory $34.24MM $12.24MM $0.00MM
Assets $251.21MM $254.60MM $197.41MM
Operating Cash Flow $-52.13MM $-67.57MM $-78.33MM
Capital expenditure $0.31MM $0.60MM $1.31MM
Investing Cash Flow $-167.63MM $12.63MM $46.22MM
Financing Cash Flow $225.05MM $72.87MM $26.71MM
Earnings Per Share* $-2.01 $-1.36 $-1.27

* EPS are Split Adjusted, recent splits may be reflected with a delay.